Anti-TNFRSF8 (Brentuximab-LC-E161)-DBCO-MMAF ADC

CAT:

708-ADC-W-262

Size:

1 mg

Price:

Ask

For price, please contact [email protected]

Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,LC-E161) conjugated via a DBCO linker to MMAF. The MMAF is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
CAS Number: 9007-83-4
Format: Solution
Shipping Conditions: Ice Packs
Storage Conditions: -20°C

Cat	Name
ADC-W-262	Anti-TNFRSF8 (Brentuximab-LC-E161)-DBCO-MMAF ADC
ADC-W-259	Anti-TNFRSF8 (Brentuximab-LC-R142)-DBCO-MMAF ADC
ADC-W-261	Anti-TNFRSF8 Brentuximab-LC-Q147)-DBCO-MMAF ADC
ADC-W-260	Anti-TNFRSF8 (Brentuximab-LC-N152)-DBCO-MMAF ADC
ADC-W-263	Anti-TNFRSF8 (Brentuximab-LC-K149)-DBCO-MMAF ADC
ADC-W-257	Anti-ERBB2 (Trastuzumab-LC-E161)-DBCO-MMAF ADC
ADC-W-249	Anti-TNFRSF8 (Brentuximab-HC-Y180)-DBCO-MMAF ADC
ADC-W-251	Anti-TNFRSF8 (Brentuximab-HC-S157)-DBCO-MMAF ADC
ADC-W-253	Anti-TNFRSF8 (Brentuximab-HC-P127)-DBCO-MMAF ADC
ADC-W-248	Anti-TNFRSF8 (Brentuximab-HC-K121)-DBCO-MMAF ADC

Cat	Name
F1043-.1	Anti-TNFRSF8/CD30 Antibody (Brentuximab)
F1043-1	Anti-TNFRSF8/CD30 Antibody (Brentuximab)
F1042-1	Anti-TNFRSF8/CD30 Antibody (Brentuximab vedotin)
T39897-1mg	DBCO-PEG4-MMAF
T39897-10mg	DBCO-PEG4-MMAF
HY-133492-01	DBCO-PEG4-MMAF
T39897-50mg	DBCO-PEG4-MMAF
MBS5800277-01	DBCO-PEG4-MMAF
T39897-5mg	DBCO-PEG4-MMAF
T39897-1g	DBCO-PEG4-MMAF